AzTrials
AzTrials

AnxietyNCT06176924

Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams

A study testing tDCS and Relaxation technique in people with Anxiety, run by Maharishi Markendeswar University (Deemed to be University) at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Anxiety is one of the most significant obstacles to academic success. When stress is interpreted negatively or becomes overwhelming, it causes anxiety before and during examinations, which in turn impacts students' academic performance. Read more about this study

Who is it for?
Ages 15 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Anxiety
What is being tested?
tDCS and Relaxation technique
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteIndia
Study dates
1 Aug 2023to 10 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Competitive Exam students only.
  • Age group between 15 years to 18 years.
  • Willingness to take part in the research.

Who cannot join

  • Non-Corporative students
  • Skin irritation

Trial locations and contacts

1 site in 1 country.

India1 site, 1 recruiting
  • MMIPR

    Ambāla, Haryana, 133207

    subhasish chatterjee, MPT(NEURO), +918950037407, subhasishphysio@gmail.com

    Mousumi Saha, MPT, +919366787310, msaha0029@gmail.com

    Recruiting

Other trials in India

About this study

Official title: Effect of tDCS Along With Relaxation Technique on Anxiety Level in Students Preparing for Competitive Exams: A Randomized Controlled Trail

Anxiety is one of the most significant obstacles to academic success. When stress is interpreted negatively or becomes overwhelming, it causes anxiety before and during examinations, which in turn impacts students' academic performance. The difficulty in managing severely associated anxiousness enhances the demand for NIBS. It is a unique approach that has the potential to alleviate anxiety by modifying cortical excitability whereas Relaxation breaks the vicious cycle of pain caused by muscular stress, circulatory illness, and metabolic by-products alterations. The main purpose is to evaluate whether tDCS along with Relaxation technique reduces the anxiety level in competitive exam students. Total 46 students are recruited and randomly allocating in experimental and control group. The subjects in the experimental group are going to receive 9 tDCS sessions (2mA, anode placed on the DLFPC of left side and cathode on right supraorbital cortex for 20 min) along with relaxation technique. Subjects in the control group are going to receive 9 sessions of relaxation. The CSAI-2R scale is used as an Outcome Measure. Samples completed the CSAI-2R scale before and following the intervention. The data will be analyzed using SPSS 26.0 software.

Conditions
Anxiety
Being tested
tDCS, Relaxation technique
Keywords
Anxiety, tDCS, Relaxation, Competitive Exam Students, 2mA, CSAI-2R
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCSDevice

    tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.

  • Relaxation techniqueOther

    Relaxation technique

Study groups in NCT06176924
Study groupRoleWhat they receive
Active tDCS and Relaxation techniqueExperimentalSubjects within an experimental group had received 9 sessions of tDCS (2mA, 20 min anode placed on DLFPC of left side and cathode on supraorbital cortex of right side) along with relaxation technique.
Receives: Device: tDCS; Other: Relaxation technique
Relaxation techniqueOtherSubjects in the control group are going to receive 9 sessions of relaxation technique
Receives: Other: Relaxation technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CSAI- 2R (Competitive State Anxiety Inventory-2R)

    It is a reliable and viable scale for assessing the level of competitive anxiety. It's having 27 components, each having 4 grades ranging from 1 to 4.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2023
  2. Study start1 Aug 2023
  3. Primary completion10 Jan 2024 (estimated)
  4. Study completion10 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06176924
Sponsor's protocol ID
SPC-PA-06
Status last verified
Dec 2023
First submitted
11 Dec 2023
Last updated
20 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing tDCS and Relaxation technique in people with Anxiety, run by Maharishi Markendeswar University (Deemed to be University) at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rama Taneja (09518260372, ramataneja.055@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CSAI- 2R (Competitive State Anxiety Inventory-2R) (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in